In this study, we aimed to explore the potential role of serum anti-JMJD6 antibodies (s-JMJD6-Abs) in inflammatory-related diseases and to consider them as biomarkers for inflammatory myocardial infarction, stroke, DM, and cancers. Here, JMJD6 is linked to diabetes mellitus.